Kemistar Corporation Ltd
₹ 63.3
-8.58%
13 Aug
- close price
About
Incorporated in 1994, Kemistar Corporation Ltd deals in various chemical based & allied products
Key Points
- Market Cap ₹ 68.1 Cr.
- Current Price ₹ 63.3
- High / Low ₹ 116 / 55.8
- Stock P/E 972
- Book Value ₹ 14.6
- Dividend Yield 0.79 %
- ROCE 1.95 %
- ROE 1.40 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 4.32 times its book value
- The company has delivered a poor sales growth of -0.92% over past five years.
- Company has a low return on equity of 1.43% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.86 | 0.96 | 0.95 | 0.99 | 2.84 | 3.11 | 4.41 | 6.21 | 6.44 | 3.79 | 4.21 | 4.21 | 3.02 | |
| 0.82 | 0.94 | 0.94 | 0.99 | 2.79 | 3.10 | 4.33 | 5.97 | 6.11 | 3.51 | 3.90 | 3.90 | 2.80 | |
| Operating Profit | 0.04 | 0.02 | 0.01 | 0.00 | 0.05 | 0.01 | 0.08 | 0.24 | 0.33 | 0.28 | 0.31 | 0.31 | 0.22 |
| OPM % | 4.65% | 2.08% | 1.05% | 0.00% | 1.76% | 0.32% | 1.81% | 3.86% | 5.12% | 7.39% | 7.36% | 7.36% | 7.28% |
| 0.00 | 0.00 | 0.01 | 0.05 | 0.04 | 0.13 | 0.19 | 0.05 | 0.01 | 0.07 | 0.02 | 0.02 | 0.05 | |
| Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.08 |
| Profit before tax | 0.03 | 0.02 | 0.02 | 0.05 | 0.09 | 0.14 | 0.22 | 0.24 | 0.29 | 0.32 | 0.31 | 0.31 | 0.15 |
| Tax % | 0.00% | 0.00% | 0.00% | 20.00% | 22.22% | 28.57% | 27.27% | 20.83% | 20.69% | 25.00% | 29.03% | 29.03% | |
| 0.02 | 0.02 | 0.02 | 0.04 | 0.07 | 0.11 | 0.17 | 0.19 | 0.23 | 0.23 | 0.22 | 0.22 | 0.07 | |
| EPS in Rs | 0.02 | 0.02 | 0.30 | 0.60 | 0.38 | 0.10 | 0.16 | 0.18 | 0.21 | 0.21 | 0.20 | 0.20 | 0.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 187.13% | 187.13% | 244.55% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 41% |
| 3 Years: | 0% |
| TTM: | -71% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 9% |
| 3 Years: | 16% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.39 | 8.39 | 0.67 | 0.67 | 1.87 | 10.76 | 10.76 | 10.76 | 10.76 | 10.76 | 10.76 | 10.76 |
| Reserves | -7.73 | -7.71 | 0.03 | 0.06 | 0.91 | 4.11 | 4.28 | 4.47 | 4.74 | 4.87 | 4.99 | 4.98 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.06 | 0.01 | 0.01 | 0.28 | |
| 0.24 | 0.15 | 0.25 | 0.31 | 0.19 | 1.17 | 1.64 | 1.69 | 1.09 | 2.08 | 1.57 | 0.06 | |
| Total Liabilities | 0.90 | 0.83 | 0.95 | 1.04 | 2.97 | 16.04 | 16.68 | 17.03 | 16.65 | 17.72 | 17.33 | 16.08 |
| 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.27 | 0.23 | 0.19 | 0.16 | 0.14 | 0.47 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.51 | 0.64 | 0.57 | 0.42 | 2.24 | 13.93 | 11.68 | 11.36 | 11.63 | 11.21 | 11.36 | 11.12 |
| 0.34 | 0.14 | 0.33 | 0.58 | 0.69 | 2.07 | 4.73 | 5.44 | 4.83 | 6.35 | 5.83 | 4.49 | |
| Total Assets | 0.90 | 0.83 | 0.95 | 1.04 | 2.97 | 16.04 | 16.68 | 17.03 | 16.65 | 17.72 | 17.33 | 16.08 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.03 | 0.16 | -0.18 | 0.00 | -2.09 | -1.11 | -0.61 | 1.13 | -0.05 | 1.11 | 0.27 | -0.03 | |
| 0.00 | -0.13 | 0.07 | 0.00 | 0.00 | -10.73 | 2.00 | 0.31 | 0.00 | 0.42 | -0.15 | -0.14 | |
| 0.00 | -0.01 | 0.00 | 0.00 | 1.92 | 11.91 | -1.38 | -1.46 | 0.00 | -1.47 | -0.09 | 0.11 | |
| Net Cash Flow | 0.03 | 0.02 | -0.11 | 0.00 | -0.17 | 0.06 | 0.01 | -0.01 | -0.05 | 0.06 | 0.02 | -0.05 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 101.86 | 7.60 | 111.42 | 129.04 | 64.26 | 59.86 | 241.68 | 130.48 | 79.91 | 182.98 | 121.38 | 6.07 |
| Inventory Days | 0.00 | 0.00 | 22.35 | 0.00 | 0.00 | 139.29 | 0.91 | 0.00 | 18.69 | 1.21 | 3.94 | 5.90 |
| Days Payable | 126.63 | 143.16 | 121.36 | 62.29 | 234.04 | 153.48 | 2.95 | |||||
| Cash Conversion Cycle | 101.86 | 7.60 | 7.14 | 129.04 | 64.26 | 55.99 | 121.22 | 130.48 | 36.31 | -49.84 | -28.16 | 9.02 |
| Working Capital Days | 8.49 | -49.43 | 26.89 | 18.43 | 51.41 | 75.11 | 238.37 | 203.95 | 203.47 | 400.63 | 356.33 | 385.81 |
| ROCE % | 6.15% | 2.99% | 1.45% | 4.20% | 2.85% | 0.11% | 0.40% | 1.32% | 1.88% | 2.05% | 1.97% | 1.95% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
22h - Newspaper Publication of the unaudited Financial results for the quarter ended June 30, 2025.
-
UN AUDITED STANALONE AND CONSOLIDATED FINANCIAL RESULTS FOR QUARTER ENDED ON 30-JUNE-2025.
2d - Unaudited Q1 FY2026 consolidated and standalone financial results approved and disclosed by Kemistar Corporation.
-
Board Meeting Outcome for Board Meeting For Approval Of Standalone And Consolidated Un- Audited Financial Results For The Quarter Ended June 30, 2025
2d - Unaudited Q1 FY2026 consolidated and standalone financial results approved and disclosed by Kemistar Corporation.
-
Board Meeting Intimation for Inter Alia To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company And To Take On Record The Limited Review Report Thereon For The Quarter Ended On June 30, 2025.
1 Aug - Board meeting on Aug 11 to approve Q1 June 2025 unaudited financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Jul
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Aug 2024TranscriptNotesPPT
-
Jul 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
Business Overview:[1]
Company is in the business of Colors, Agro Chemicals and Specialty Chemicals, raw
materials and chemical intermediate like PNTOSA, DNSDA, DASDA and allied products. Currently, company is dealing in 50+ variants of chemical products.